Benvenuto et al. used an SMO inhibitor (GDC-0449) and GLI inhibitor (GANT-61) to target the SHH/GLI pathway to inhibit breast cancer cell growth in both in vitro and in vivo studies [136]. The gene discussed is SMO; the disease is breast carcinoma.